Adelene Q Perkins
CIK 1375124 · Chief Executive Officer · last filed 2026-02-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.03M
Companies
3
Total Filings
53
Lifetime Open-Market Net
-$1.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BRKRP | Director | 29,144 | $401.31 | $11.70M | $0 | 1 | 2026-02-18 |
| BRKR | Director | 24,624 | $54.23 | $1.34M | $0 | 9 | 2025-02-19 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Chief Executive Officer | 1,601,933 | $0.04 | $71.6K | -$1.63M | 43 | 2023-09-12 |
Recent Filings · Page 6 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-05-08 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Buy (P) | +15,148 | $167.1K | EDGAR |
| 2007-05-07 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Buy (P) | +3,052 | $34.5K | EDGAR |
| 2007-01-29 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 51–53 of 53
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.